Navigation Links
AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test
Date:7/14/2008

e significantly higher across all types of gastrointestinal cancers tested and not limited to specific tumor types, suggesting the AMDL-ELISA DR-70 (FDP) test could be clinically used as a global cancer detection tool.

According to the results:

-- The AMDL-ELISA DR-70 (FDP) test showed strong clinical performance

with a sensitivity of 91% and a specificity of 93% in testing

conducted on patients with hepatocellular, cholangiocellular,

pancreatic, colorectal, stomach and oesophagus cancers.

-- The test reliably differs between patients with cancer of the

gastrointestinal tract or the hepatobilary system and healthy

patients; therefore showing promise as a useful cancer detection tool

in clinical practice.

-- The study also found an association between the quantitative DR-70

value and the stage of the cancer in patients tested which suggests

the AMDL-ELISA DR-70 (FDP) test can also be used as a prognostic

factor in cancer monitoring.

About AMDL: Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs approximately 320 people in the U.S. and China. The AMDL ELISA DR-70 (FDP) cancer diagnostic test was cleared to market by the US FDA on July 13, 2008 and the Company has 4 additional pharmaceutical and diagnostic products under review by various regulatory authorities. For additional information on AMDL and its products visit the company's website at http://www.amdl.com or call +1 (714)505-4460.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations<
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
2. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
3. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
4. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
5. Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
6. Promising Data ATIR Studies Presented by NIH Investigators
7. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
8. Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction
9. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
10. Mega-Brand Success: Effective Market Strategy and Tactics
11. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... today announced it has initiated commissioning activities for its ... Sarnia, Ontario , Canada.  ... months, with the facility being in commercial operation in ... in two months and it is carrying out commissioning ...
(Date:3/3/2015)... FL (PRWEB) March 03, 2015 ... company’s growing faculty. Camacho Alcocer, a biomedical researcher and ... Mexico, will join GSCG’s team of biomedical professors who ... Engineering” program. , Criogenix SA de CV is a ... and Technological Institutions and Companies in Mexico (RENIECYT). , ...
(Date:3/2/2015)... March 02, 2015 The American ... announced today the launch of Genetically Speaking ... healthcare professionals on the application of human genetics in ... features peer-to-peer interviews conducted during the ASHG 2014 Annual ...     Translational Genomics and Health Outcomes Research: What's Ready for ...
(Date:3/2/2015)... In the five years to 2015, the ... growth. The industry, which consists of companies that perform ... other goods, has grown on account of an improving ... IBISWorld forecasts that industry revenue will increase at an ... the five-year period, including an anticipated increase of 2.8% ...
Breaking Biology Technology:BioAmber Begins Commissioning of Sarnia Commercial Plant 2BioAmber Begins Commissioning of Sarnia Commercial Plant 3Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 2Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 3American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 2American Society of Human Genetics (ASHG) and ReachMD Launch Series on Genetics and Genomics 3Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 2Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 3
... Microchip Biotechnologies,Inc. (MBI) announces that it ... GE Healthcare that significantly enhances MBI,s intellectual,property ... The,patents cover design and methods for creating ... patents continues to build our strong,intellectual property ...
... were met ... TSX Exchange Symbol: RVX, ... (TSX:RVX) announced today that it has,completed dosing of its Phase ... RVX-208, which addresses the,dyslipidemia market. "Initial results from the emerging ...
... the Diagnosis of Uncertain ... ... Diagnostics, Inc.,a genomics-based diagnostics company focused on oncology, today announced,the launch ... Laboratory. The new test aids in the diagnosis of,tumors of uncertain ...
Cached Biology Technology:Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents 2Dosing for RVX-208 Phase 1a Clinical Study Completed 2Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory 2Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory 3
(Date:2/24/2015)... YORK , Feb. 24, 2015 This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the ... provided for these markets. Market data and analytics are derived ...
(Date:2/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND ... new groundbreaking payment method. Payment accounts may be selected ... be accessed if both the speech (the word associated ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... an atom donates an electron to another atom. It ... of intense research because of the implications it has ... transfer takes place in a few quadrillionths (10-15) of ... event requires very time-sensitive techniques like ultrafast spectroscopy. However, ...
... physical environment for many things clean water, land for ... Yet it has been challenging to figure out how to ... "ecosystem services" in any given landscape because an improvement ... Two ecologists at the University of WisconsinMadison report this ...
... New materials and potential new drug targets are just some ... meeting on the structure of molecules. More information on the ... The Annual Meeting of the American Crystallographic Association (ACA) ... Sheraton Waikiki Beach Hotel in Honolulu, Hawaii. Crystallography is the ...
Cached Biology News:Solving electron transfer 2Mapping the benefits of our ecosystems 2Mapping the benefits of our ecosystems 3New materials, progress toward an HIV vaccine, and more at meeting of crystallographers 2New materials, progress toward an HIV vaccine, and more at meeting of crystallographers 3
Direct ELISA Assay Diluent - EDTA, 10 L...
... Immunogen: Synthetic peptide derived from the ... Specificity: Specific for the internall ... Reactivity: Mouse (positive controls: mouse brain ... tissues). Applications: Western blotting Immunohistochemistry(froz) ...
... routine agarose gel electrophoresis into an automated, ... This bufferless, pre-cast system is ideal for ... digests, and more. Fully automated, robot-compatible, and ... 96 system makes your high-throughput screening assignments ...
...
Biology Products: